These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6742722)

  • 21. [Clinical experience with fosfomycin in urinary tract infections (author's transl)].
    Peters HJ; Eicher R
    MMW Munch Med Wochenschr; 1981 May; 123(18):748-50. PubMed ID: 6785627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
    Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
    J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phosphomycin for the prevention of bacterial infections in high risk patients].
    Faedda R; Tocco A; Vacca R; Deplano A; Olmeo NA; Branca FG; Bartoli E
    Clin Ter; 1981 Nov; 99(3):295-304. PubMed ID: 7307457
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention of surgical infections with fosfomycin].
    Germiniani R; Colombo F; Lavorato F
    G Ital Chemioter; 1978; 25(2):115-22. PubMed ID: 755790
    [No Abstract]   [Full Text] [Related]  

  • 25. [Fosfomycin: a further clinical contribution in oral cavity pathology].
    Gualandi G; Cornacchia N; Bondi MG
    Clin Ter; 1984 Oct; 111(1):53-6. PubMed ID: 6238780
    [No Abstract]   [Full Text] [Related]  

  • 26. High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.
    Schintler MV; Traunmüller F; Metzler J; Kreuzwirt G; Spendel S; Mauric O; Popovic M; Scharnagl E; Joukhadar C
    J Antimicrob Chemother; 2009 Sep; 64(3):574-8. PubMed ID: 19578081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibacterial chemotherapy--strict indications and developmental trends].
    Handrick W; Spencker FB; Braun W
    Padiatr Grenzgeb; 1986; 25(1):11-22. PubMed ID: 3960551
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fosfomycin, a new antibiotic for wound infections].
    Henneking K; Schultheis KH
    Med Klin Prax; 1982 Jun; 77(13):44-8. PubMed ID: 7110028
    [No Abstract]   [Full Text] [Related]  

  • 29. [Empirical selection of antimicrobial agents for newborn infants].
    Nasrralah E; Calderón-Jaimes E
    Bol Med Hosp Infant Mex; 1985 Oct; 42(10):587-9. PubMed ID: 4074479
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical use of fosfomycin in bacterial infections of the oral cavity in childhood].
    Ghezzi F; Zallio F
    Minerva Stomatol; 1985; 34(4):703-6. PubMed ID: 3862951
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotics in the newborn.
    McCraken GH
    Can Med Assoc J; 1975 Sep; 113(6):564-70. PubMed ID: 1156985
    [No Abstract]   [Full Text] [Related]  

  • 32. [Macrolides in pediatric practice].
    Baráibar R
    Enferm Infecc Microbiol Clin; 1989 Nov; 7(9):462-5. PubMed ID: 2490475
    [No Abstract]   [Full Text] [Related]  

  • 33. The treatment of bacterial infections in the newborn infant.
    Dashefsky B; Klein JO
    Clin Perinatol; 1981 Oct; 8(3):559-77. PubMed ID: 7030577
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of the analgesic effect of fosfomycin in odontostomatological infections].
    Dolci G; Ricca L; Vergnani M
    Clin Ter; 1982 Jul; 102(1):59-65. PubMed ID: 7140171
    [No Abstract]   [Full Text] [Related]  

  • 35. Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis.
    Faruqi S; McCreanor J; Moon T; Meigh R; Morice AH
    Int J Antimicrob Agents; 2008 Nov; 32(5):461-3. PubMed ID: 18703318
    [No Abstract]   [Full Text] [Related]  

  • 36. [Various aspects of bacterial infections in infants].
    Jankowski A
    Przegl Epidemiol; 1981; 35(3):319-25. PubMed ID: 7330240
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bacterial endophthalmitis: treatment with a combination of fosfomycin and pefloxacin apropos of 9 cases].
    Salvanet-Bouccara A; Feys J; Koffi-Gue B; Fisch A; Cherifi M; Forestier F
    Bull Soc Ophtalmol Fr; 1989 Nov; 89(11):1281-6. PubMed ID: 2630133
    [No Abstract]   [Full Text] [Related]  

  • 38. Fosfomycin in acute bronchopneumopathies.
    Honorato J; Pérez Ortola R; Masso R; Reparaz JM
    Chemotherapy; 1977; 23 Suppl 1():331-6. PubMed ID: 832533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro-in vivo paradox.
    Scortti M; Lacharme-Lora L; Wagner M; Chico-Calero I; Losito P; Vázquez-Boland JA
    Nat Med; 2006 May; 12(5):515-7. PubMed ID: 16633349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Infection resistance to antibiotics].
    Ansorg R
    Hippokrates; 1973 Dec; 44(4):389-93. PubMed ID: 4779542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.